les, 10 females, age 15.1 years (10-17 years)) 14-10 never had glucosuria were carrpared with 21 age and sex matched healthy children (controls 
Pekka Ahonen, Aaro Pliettinen, and Jaakko Perheentupa. The Children's Hospital and the Department of Bacteriology and Imunology, University of Helsinki, Finland. We studied steroid cell (ovary, testis, placenta) (SCA) and adrenal (M) antibodies in 311 serum samples collected from the Finnish whole-population-based series of 47 patients with APECED during 1.3-13 (mean 7.3) years. 15 patients had no antibodies. 3 patients had AA alone, 28 had AA+SCA and 1 patient had SCA alone. AA and/or SCA were observed in 30134 patients vith adrenocortical failure (A) and in 4/13 without A (p=0.0002), in 13/13 females with ovarian failure (0) and in 7/13 females without 0 (P= 0.01). A was observed to develop in 12/25 patients. AA or SCA appeared in 11/12 of them in contrast to 4/13 of patients maintaining normal adrenal function (p=0.003).
0 was observed to develop in 10123 patients. In 10/10 of then M and SCA appeared in contrast to 7/13 females maintaining normal ovarian function (p=O.OZ). SCA were detected in 29/47 patients, in contrast to 617 patients of Elder (JCEEI 1981 (JCEEI :52:1137 ) who all had a multicomponent disease. 5/16 of our patients with no or 1 endocrinopathy, 8/13 of those with 2 and 16/18 of those with 3 or more endocrinopathies had SCA. Thus SCA were commoner in patients with multicomponent endocrinopathy (p-0.003). 
VITAMIN D METABOLISM IN MALE PUBERTY
The increased growth and mineralization together with higher serum levels of 1.25(OHI2D3 in puberty compared to adult levels may indicate a regulatory role of sexhormones in vitamin D metabolism. Twenty pubertal boys, aged 11.0-12.6 years, were included in a 2-year study. Local bone mineral content (BMC), serum levels of testosterone (T), 250HD , 1.?5(OH) D , 24.25(0H) D , and 25.26(0Hj D have been determ?ned at 3 mgn3hs i n t e r~a l z .~~ curve fitting2ai?alysis was performed to define the time (t ) at which T and BMC displayed the maximal increase. t for T gc- :190, 1981) showed that infusion of bovine PTH at physiological revised to cranlometapfyseal dyspla~sa (CMD) based on mandibular sclerosis and normal density of the vetebrae. by 2 dose (0-3-0.5 ulkg) in thyroparathyroidectcmized dogs ~roduced months of a e, hepatosplenomegaly had,resolved, but the base phosphaturia and a reduction in urinary Ca excretion, but no of the skul? had become more sclerotic and there was no increase in urinary excretion or renal tissue content of c.OP, improvement of facial nerve function. Parameters from an iliac crest bio sy included: trabecular bone volume 15.1%
suggesting that some effects of PTH may be mediated by mechanisms (25~3%); osteocPast surface area, 2.6% (1.1+0.3%).' and other than CAMP. In order to assess whether similar phenomena osteoclast number/mm trabecular bone surfa7e 6.37 can be observed in human, we infused human PTH, 1-34, at 0.3 u/kg (0.12+0.02).
All these garameters differ signif:canly from childKood norms (+St)). steoblastic parameters were normal. and 3 u/kg in 5 normal adults and measured urinary CAMP (UcAMP), The atient was bBgun on high dosq (1.5 mcg/kg/d] calcitriol %TRP, Ca, Mg, Na, K, and plasma CAMP (PeAMP) in the next 3 hours.
(HofPmann-~a-~oche) and a low calclum (15 mg/kg/d diet (ROSS As shown in the table, PTH at 0.3 u/kg induced phosphaturia of a Laboratories). After 7 months of therapy, the facial nerve palsy had improved. Raiographs of the base of the skull similar magnitude and a comparable urinary excretion of electrodemonstrated decreased density. A CT demonstrated increased lytes to that of 3 u/kg but PcAMP and UcAMP were markedly differsize of optic foramina and internal auditory canals. A reapeat ent. After 0.3 u/kr. there was no rise in PchT. and a small . -. iliac crest biopsy showed decreased osteoclast number and increased trabecular bone volume.
rise in UcAMP indicating a difference in handling and production In CMD sclerosis of the cranium has increased throughout of CAMP after physiological and pharmacological dose of PTH. early chtldhood in all reported cases. In our patient high PTH APcAMP AUcAMF ATRP dose calcitriol reversed the cranial sclerosis withbut stimulating excessive bone loss from other, less sclerotic (u/kg) (pmol/ml) (nmol/min/lOOmlCcr) 
